Cargando…
COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development
In 2019, an unprecedented disease named coronavirus disease 2019 (COVID-19) emerged and spread across the globe. Although the rapid transmission of COVID-19 has resulted in thousands of deaths and severe lung damage, conclusive treatment is not available. However, three COVID-19 vaccines have been a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Pharmaceutical Society of Korea
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161353/ https://www.ncbi.nlm.nih.gov/pubmed/34047940 http://dx.doi.org/10.1007/s12272-021-01331-9 |